-The Guardian Half of Indians have no toilet. It's one of many gigantic failures that have prompted Nobel prize-winning academic Amartya Sen to write a devastating critique of India's economic boom The roses are blooming at the window in the immaculately kept gardens of Trinity College, Cambridge and Amartya Sen is comfortably ensconced in a cream armchair facing shelves of his neatly catalogued writings. There are plenty of reasons for satisfaction...

-The Guardian A landmark bill to make the right to food a legal entitlement is mired in controversy over its failure to address a flawed public food distribution system, misplaced priorities and exclusions India has an over abundance of food grains stocked in warehouses, yet millions of India's poor are left without food. Development practitioners and NGOs are in favour of disbanding the current food security system, the public distribution system (PDS),...

-The Telegraph Kolkata: Two books by celebrated economists have set the stage for an absorbing growth battle. Columbia University professor Jagdish Bhagwati and Nobel laureate Amartya Sen want the same end - a better India - but the means they prescribe sound different. If Bhagwati prescribes economic growth led by the markets and overseen and encouraged by liberal state policies, Sen believes growth cannot be an end in itself without government effort to...

-The Hindu     The much-awaited Drug (Prices Control) Order 2013 has disappointed millions of patients, as it lacks a fair formula to fix the price ceiling and leaves important drug classes out of regulation. The result: High out-of-pocket spending on medicines will continue As far as intentions go, the Drug (Prices Control) Order 2013 is aimed at making critical drugs affordable and available to the public, while preserving a rationale for manufacture by...

-The Hindu The current market prices are essentially over and above the actual cost of production - a difference that could run from 100 per cent to 5,600 per cent, depending upon various therapeutic categories In a liberalised market economy, do we need price controls on drugs? Policymakers and the pharmaceutical industry do not think so. They believe that price controls are an inefficient tool that distorts resource allocation, squeezes revenue, reduces...